⌘K

Login Start Free

Home/Filings/4/0001209191-20-024502

4//SEC Filing

Yanni Barbara 4

Accession 0001209191-20-024502

CIK 0001662524other

View on SEC.gov Company Profile

Filed

Apr 14, 8:00 PM ET

Accepted

Apr 15, 5:09 PM ET

Size

5.2 KB

Accession

0001209191-20-024502

Insider Transaction Report

Form 4

Period: 2020-04-13

AKCEA THERAPEUTICS, INC.AKCA

Director

Transactions

Award
Stock Option (right to buy)
2020-04-13+26,400→ 26,400 total
Exercise: $16.14Exp: 2030-04-12→ Common Stock (26,400 underlying)

Footnotes (1)

[F1]The shares vest on the 12-month anniversary of the date of grant.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

AKCEA THERAPEUTICS, INC.

CIK 0001662524

Entity typeother

Related Parties

1

filerCIK 0001610561

Filing Metadata

Form type: 4
Filed: Apr 14, 8:00 PM ET
Accepted: Apr 15, 5:09 PM ET
Size: 5.2 KB

View on SEC.gov